Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma

Journal of Immunology

Volumn 165, Issue 5, 2000, Pages 2651-2656

  Bellone, M ^a   Cantarella, D ^a   Castiglioni, P ^a   Crosti, M C ^a   Ronchetti, A ^a   Moro, M ^a   Garancini, M P ^a   Casorati, G ^a   Dellabona, P ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIAL TOXIN; CANCER VACCINE; TUMOR ANTIGEN; TYROSINASE RELATED PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; IMMUNOGENICITY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION;

EID: 0034283948     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.5.2651     Document Type: Article

References (34)

1. Cancer vaccines
2. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
3. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo
4. Rejection of a nonimmunogenic melanoma by vaccination with natural melanoma peptides on engineered antigen-presenting cells
5. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells
6. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
7. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma
8. The use of melanosomal proteins in the immunotherapy of melanoma
9. Dendritic cells and the control of immunity
10. Dendritic cell vaccines for cancer immunotherapy
11. Cancer immunotherapy: Synthetic and natural peptides in the balance
12. DNA vaccines: Immunology, application, and optimization
13. Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice
14. DNA-based immunization by in vivo transfection of dendritic cells
15. DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
16. Immunization through dermal delivery of protein-encoding DNA: A role for migratory dendritic cells
17. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major
18. New approaches to mucosal immunization
19. Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: Selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue
20. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity
21. Introduction of soluble protein into the class I pathway of antigen processing and presentation
22. Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis
23. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function
24. Role of antigen presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells
25. B7.1 expression on tumor cells circumvents the need of professional antigen presentation for in vitro propagation of cytotoxic T cell lines
26. Principles of tumor immunity: Tumor antigens
27. Exact prediction of a natural T cell epitope
28. Immunological tolerance
29. Evidence for a different avidity model of T cell selection in the thymus
30. High avidity CTL for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy
31. Immunogenicity and antigen structure
32. The duration of antigenic stimulation determines the fate of naive and effector T cells
33. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage
34. DNA vaccination with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma